Anbio Biotechnology Class A Ordinary Shares

NNNNNASDAQHealthcare● Active

$17.22

$-5.77(-25.10%)

Market Cap$755806464

P/E Ratio—

52W High$55.65

52W Low$7.92

Avg Volume28K

Open$22.68

Beta4.34

PE Ratio Market Cap Forecast

Anbio Biotechnology Class A Ordinary Shares (NNNN) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

nnnn · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Anbio Biotechnology Class A Ordinary Shares (NNNN) measures how much investors pay for each dollar of the company's trailing earnings. NNNN's current PE ratio of 105.17x is calculated by dividing its stock price of $17.22 by its TTM earnings per share of $0.16. −45.5% discount vs 5Y avg 192.9x

105.17x

P/E Ratio (TTM)−45.5%

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E

N/A

—

EPS (TTM)

$0.16

TTM · diluted EPS

PEG Ratio

1.05

▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Anbio Biotechnology Class A Ordinary Shares SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-08

PE Ratio History

2021 – 2025 · Annual

PE Ratio (TTM)

5Y Avg 192.9x

EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

Historical PE Range

Past 5 fiscal years · Front-end computed

Average

192.9x

5-yr mean

Median

182.6x

5-yr midpoint

Minimum

82.9x

Lowest year

Maximum

368.4x

Highest year

105.2x ← Now

82.9x
MinQ1 · 25%182.6x
MedianQ3 · 75%368.4x
Max

Within Historical Range

At 105.17x, NNNN's current P/E is within its average historical range over the past 5 fiscal years.

40th percentileHigher than 2 of 5 historical fiscal year readings

Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.

PE Ratio vs Peers

Medical - Instruments & Supplies · 6 peers · Annual PE

Company	Market Cap	PE (Annual)	vs Avg	EPS (TTM)
Anbio Biotechnology Class A Ordinary SharesYou NNNN	$756M	105.17x	—	$0.16
AngioDynamics, Inc. ANGO	$493M	N/A	—	-$0.83
Avanos Medical, Inc. AVNS	$1.2B	N/A	—	-$1.46
ClearPoint Neuro, Inc. CLPT	$401M	N/A	—	-$0.90
COMPASS Pathways plc CMPS	$1.1B	N/A	—	-$3.08
Community Health Systems, Inc. CYH	$389M	0.82x	—	$3.80
Gossamer Bio, Inc. GOSS	$39M	N/A	—	-$0.75

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 5 of 5 years

Fiscal Year End	PE Ratio	EPS (TTM)	YoY Change
2025-12-31Latest FY2025	182.63x	$0.16	+77.6%
2024-12-31 FY2024	102.84x	$0.06	-72.1%
2023-12-31 FY2023	368.39x	$0.02	+344.2%
2022-12-31 FY2022	82.93x	$0.07	-63.6%
2021-12-31 FY2021	227.54x	$0.03	—

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

PE Ratio = Stock Price ÷ EPS (TTM)

= $17.22 ÷ $0.16 = 105.17x

TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures

Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year

PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium

Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Price history Financial statements Earnings

Frequently asked questions

NNNN pe ratio · 6 questions

NNNN's current PE ratio is 105.17x as of 2026-06-08, based on a stock price of $17.22 and TTM EPS of $0.16. Data sourced from Financial Modeling Prep via NNNN's SEC 10-K and 10-Q filings.

NNNN PE ratioWhat is NNNN PE ratioCurrent PE ratio of NNNNNNNN PE ratio today

▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Anbio Biotechnology Class A Ordinary Shares SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08